vs

Side-by-side financial comparison of CUMBERLAND PHARMACEUTICALS INC (CPIX) and FRANKLIN WIRELESS CORP (FKWL). Click either name above to swap in a different company.

CUMBERLAND PHARMACEUTICALS INC is the larger business by last-quarter revenue ($13.7M vs $11.9M, roughly 1.1× FRANKLIN WIRELESS CORP). FRANKLIN WIRELESS CORP runs the higher net margin — 4.5% vs -10.3%, a 14.8% gap on every dollar of revenue. On growth, CUMBERLAND PHARMACEUTICALS INC posted the faster year-over-year revenue change (31.1% vs -33.1%). CUMBERLAND PHARMACEUTICALS INC produced more free cash flow last quarter ($3.0K vs $-4.1M). Over the past eight quarters, FRANKLIN WIRELESS CORP's revenue compounded faster (39.0% CAGR vs 26.9%).

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company that develops, manufactures and commercializes branded prescription medicines. Its core product portfolio covers acute care, gastroenterology, pain management and rare disease treatment, with its primary operating market being the United States, serving healthcare providers and patients in relevant care segments.

Viaero Wireless is a regional wireless telecommunications company that provides direct coverage in Nebraska, eastern Colorado, western Kansas, and southeastern Wyoming. Based in Fort Morgan, Colorado, Viaero is often the primary cell tower owner in portions of its coverage area. Through roaming coverage partner relationships, Viaero customers can place and receive calls locally and across the country, internationally, and on cruise ships.

CPIX vs FKWL — Head-to-Head

Bigger by revenue
CPIX
CPIX
1.1× larger
CPIX
$13.7M
$11.9M
FKWL
Growing faster (revenue YoY)
CPIX
CPIX
+64.2% gap
CPIX
31.1%
-33.1%
FKWL
Higher net margin
FKWL
FKWL
14.8% more per $
FKWL
4.5%
-10.3%
CPIX
More free cash flow
CPIX
CPIX
$4.1M more FCF
CPIX
$3.0K
$-4.1M
FKWL
Faster 2-yr revenue CAGR
FKWL
FKWL
Annualised
FKWL
39.0%
26.9%
CPIX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CPIX
CPIX
FKWL
FKWL
Revenue
$13.7M
$11.9M
Net Profit
$-1.4M
$533.6K
Gross Margin
83.6%
17.1%
Operating Margin
-10.0%
0.4%
Net Margin
-10.3%
4.5%
Revenue YoY
31.1%
-33.1%
Net Profit YoY
25.8%
133.3%
EPS (diluted)
$-0.09
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPIX
CPIX
FKWL
FKWL
Q4 25
$13.7M
$11.9M
Q3 25
$8.3M
$12.7M
Q2 25
$10.8M
$6.9M
Q1 25
$11.7M
$8.0M
Q4 24
$10.4M
$17.8M
Q3 24
$9.1M
$13.3M
Q2 24
$9.8M
$6.1M
Q1 24
$8.5M
$6.2M
Net Profit
CPIX
CPIX
FKWL
FKWL
Q4 25
$-1.4M
$533.6K
Q3 25
$-1.9M
$640.5K
Q2 25
$-740.7K
$-342.2K
Q1 25
$1.3M
$-644.8K
Q4 24
$-1.9M
$228.7K
Q3 24
$-1.5M
$515.2K
Q2 24
$-1.1M
$-1.8M
Q1 24
$-1.9M
$-1.2M
Gross Margin
CPIX
CPIX
FKWL
FKWL
Q4 25
83.6%
17.1%
Q3 25
88.1%
22.8%
Q2 25
81.4%
18.0%
Q1 25
87.8%
16.9%
Q4 24
81.1%
18.2%
Q3 24
85.4%
15.5%
Q2 24
82.6%
10.5%
Q1 24
81.5%
8.4%
Operating Margin
CPIX
CPIX
FKWL
FKWL
Q4 25
-10.0%
0.4%
Q3 25
-23.7%
4.6%
Q2 25
-6.9%
-19.0%
Q1 25
11.0%
-24.6%
Q4 24
-17.7%
4.5%
Q3 24
-18.6%
-2.8%
Q2 24
-10.4%
-36.7%
Q1 24
-22.0%
-25.2%
Net Margin
CPIX
CPIX
FKWL
FKWL
Q4 25
-10.3%
4.5%
Q3 25
-23.4%
5.0%
Q2 25
-6.8%
-4.9%
Q1 25
10.7%
-8.1%
Q4 24
-18.2%
1.3%
Q3 24
-17.0%
3.9%
Q2 24
-11.0%
-28.9%
Q1 24
-22.9%
-19.0%
EPS (diluted)
CPIX
CPIX
FKWL
FKWL
Q4 25
$-0.09
$0.05
Q3 25
$-0.13
$0.05
Q2 25
$-0.05
$-0.03
Q1 25
$0.08
$-0.05
Q4 24
$-0.13
$0.02
Q3 24
$-0.11
$0.04
Q2 24
$-0.08
$-0.16
Q1 24
$-0.14
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPIX
CPIX
FKWL
FKWL
Cash + ST InvestmentsLiquidity on hand
$11.4M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$24.9M
$35.1M
Total Assets
$76.8M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPIX
CPIX
FKWL
FKWL
Q4 25
$11.4M
$24.3M
Q3 25
$15.2M
$25.3M
Q2 25
$16.1M
$25.9M
Q1 25
$15.1M
$25.3M
Q4 24
$18.0M
$21.9M
Q3 24
$17.5M
$40.7M
Q2 24
$17.3M
$37.5M
Q1 24
$18.5M
$31.7M
Stockholders' Equity
CPIX
CPIX
FKWL
FKWL
Q4 25
$24.9M
$35.1M
Q3 25
$26.1M
$35.1M
Q2 25
$28.0M
$34.5M
Q1 25
$28.7M
$35.3M
Q4 24
$22.9M
$36.0M
Q3 24
$24.8M
$35.8M
Q2 24
$26.3M
$35.1M
Q1 24
$27.5M
$36.9M
Total Assets
CPIX
CPIX
FKWL
FKWL
Q4 25
$76.8M
$53.0M
Q3 25
$65.9M
$53.3M
Q2 25
$67.9M
$51.3M
Q1 25
$69.9M
$49.7M
Q4 24
$75.6M
$54.5M
Q3 24
$76.7M
$51.6M
Q2 24
$78.5M
$46.7M
Q1 24
$81.5M
$50.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPIX
CPIX
FKWL
FKWL
Operating Cash FlowLast quarter
$3.0K
$-4.1M
Free Cash FlowOCF − Capex
$3.0K
$-4.1M
FCF MarginFCF / Revenue
0.0%
-34.3%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
-7.66×
TTM Free Cash FlowTrailing 4 quarters
$4.8M
$-9.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPIX
CPIX
FKWL
FKWL
Q4 25
$3.0K
$-4.1M
Q3 25
$187.2K
$-1.5M
Q2 25
$843.8K
$2.3M
Q1 25
$3.9M
$-5.9M
Q4 24
$1.9M
$2.7M
Q3 24
$475.5K
$2.7M
Q2 24
$-855.7K
$6.2M
Q1 24
$-2.1M
$-779.0K
Free Cash Flow
CPIX
CPIX
FKWL
FKWL
Q4 25
$3.0K
$-4.1M
Q3 25
$163.4K
$-1.5M
Q2 25
$817.3K
$2.3M
Q1 25
$3.9M
$-5.9M
Q4 24
$1.9M
$2.7M
Q3 24
$460.1K
$2.6M
Q2 24
$-862.8K
$6.2M
Q1 24
$-2.2M
$-816.0K
FCF Margin
CPIX
CPIX
FKWL
FKWL
Q4 25
0.0%
-34.3%
Q3 25
2.0%
-11.7%
Q2 25
7.5%
33.6%
Q1 25
32.9%
-73.7%
Q4 24
18.2%
15.4%
Q3 24
5.1%
19.9%
Q2 24
-8.8%
101.3%
Q1 24
-25.6%
-13.2%
Capex Intensity
CPIX
CPIX
FKWL
FKWL
Q4 25
0.0%
0.1%
Q3 25
0.3%
0.0%
Q2 25
0.2%
0.1%
Q1 25
0.4%
0.0%
Q4 24
0.0%
0.0%
Q3 24
0.2%
0.2%
Q2 24
0.1%
0.0%
Q1 24
0.5%
0.6%
Cash Conversion
CPIX
CPIX
FKWL
FKWL
Q4 25
-7.66×
Q3 25
-2.32×
Q2 25
Q1 25
3.10×
Q4 24
11.99×
Q3 24
5.18×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons